Therapeutic Advances in Gastroenterology
IF
4.41
Papers
636
Papers 842
1 page of 85 pages (842 results)
Newest
#1Daniel Segna (University of Bern)H-Index: 4
#2Nele Brusselaers (Science for Life Laboratory)H-Index: 29
Last. Benjamin Misselwitz (University of Bern)H-Index: 33
view all 5 authors...
Introduction null The use of proton-pump inhibitors (PPI) may be associated with an increased risk of gastric cancer (GC). null Objective null To review and meta-analyse available literature investigating the association between PPI use and GC risk. null Methods null Two independent reviewers systematically searched Ovid MEDLINE, EMBASE, and Cochrane Library (inception to July 2020) for case-control and cohort studies assessing the association between PPI use and GC according to a predefined pro...
Source
#1Henit Yanai (Rabin Medical Center)H-Index: 20
#2Hadar Amir Barak (Rabin Medical Center)
Last. Elena Didkovsky (TAU: Tel Aviv University)H-Index: 3
view all 15 authors...
Background and Aims:Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading to dermatological consults and treatme...
Source
#1Cristina BezzioH-Index: 12
#2Marta Vernero (UNIPV: University of Pavia)H-Index: 6
Last. Simone SaibeniH-Index: 32
view all 5 authors...
Endoscopic evaluation with histological sampling is the gold standard for the diagnosis and follow-up of patients with inflammatory bowel disease (IBD), but in the past few years, gastrointestinal ...
Source
A bibliometric analysis was performed using a machine learning bibliometric methodology in order to evaluate the research trends in locally advanced rectal cancer treatment between 2000 and 2020. Information regarding publication outputs, countries, institutions, journals, keywords, funding, and citation counts was retrieved from Scopus database. During the search process, a total of 2370 publications were identified. The vast majority of papers originated from the United States of America, refl...
Source
#1Bani Ahluwalia (University of Gothenburg)H-Index: 4
#2Maria K. Magnusson (University of Gothenburg)H-Index: 23
Last. Magnus Simrén (University of Gothenburg)H-Index: 78
view all 7 authors...
Background:Aloe barbadensis Mill. (Aloe) extract was found to be well-tolerated, safe and showed beneficial effects in subsets of irritable bowel syndrome (IBS) patients in two randomized, double-b...
Source
#1SR Sharpton (UCSD: University of California, San Diego)H-Index: 1
#2Nobuharu Tamaki (UCSD: University of California, San Diego)H-Index: 22
Last. Rohit Loomba (UCSD: University of California, San Diego)H-Index: 99
view all 9 authors...
Introduction:Two-dimensional shear wave elastography (2D-SWE) and vibration-controlled transient elastography (VCTE) provide noninvasive assessment of hepatic fibrosis. We compared performance of 2...
Source
#1Brigitta Teutsch (PTE: University of Pécs)H-Index: 1
#2Eszter Boros (PTE: University of Pécs)
Last. Hegyi Péter (PTE: University of Pécs)
view all 11 authors...
Background Small bowel enteropathy (SBE) is a complication of nonsteroidal anti-inflammatory drug (NSAID) therapy occurring in 71% of NSAID users. We aimed to analyse the efficacy and safety of medications to prevent and treat NSAID-induced SBE in randomized controlled trials (RCTs). Methods This review was registered on PROSPERO (CRD42021223371). We systematically searched four databases until 20 October for comparing mucoprotective (MP), antibiotic and probiotic treatments to placebo, proton-p...
Source
#1Simon Hirschmann (FAU: University of Erlangen-Nuremberg)H-Index: 9
#2Sarah Fischer (FAU: University of Erlangen-Nuremberg)H-Index: 7
Last. Raja Atreya (FAU: University of Erlangen-Nuremberg)H-Index: 46
view all 8 authors...
Anti-tumor necrosis factor (TNF) antibodies have become an indispensable part in the therapeutic landscape of treating inflammatory bowel disease (IBD) patients. Nevertheless, they can be associated with the occurrence of severe systemic side effects. Here, we report the case of a 23-year-old patient with ileocolonic Crohn's disease in endoscopic remission under ongoing anti-TNF infliximab therapy with occurrence of novel generalized arthralgia, pleuritic chest pain, and dyspnea. Clinical, labor...
Source
#1Helge L. Waldum (NTNU: Norwegian University of Science and Technology)H-Index: 61
#2Tom C. Martinsen (NTNU: Norwegian University of Science and Technology)H-Index: 14
Source
#1Bharati Kochar (Harvard University)H-Index: 12
#2Ariela R. Orkaby (Harvard University)H-Index: 13
Last. Christine S. RitchieH-Index: 58
view all 4 authors...
Inflammatory bowel diseases (IBD), consisting of Crohn's disease and ulcerative colitis, are chronic remitting, relapsing inflammatory conditions of the gastrointestinal tract. While traditionally a disease of younger ages, the number of older adults with IBD is rising rapidly. Patients with IBD often experience geriatric syndromes at earlier ages. Older adults with IBD have poorer disease and treatment-related outcomes compared with younger adults with IBD. Applying the principles of geriatrics...
Source
12345678910
Top fields of study
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.